Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug interactions with fibric acids

A Lozada1, C A Dujovne

  • 1Division of Clinical Pharmacology, University of Kansas Medical Center, KU Hospital, Kansas City 66160-7374.

Pharmacology & Therapeutics
|August 1, 1994
PubMed
Summary

Fibrates, used to treat dyslipidemia and reduce heart disease risk, can interact with other medications. Understanding these drug interactions is crucial for safe and effective clinical use.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and efficacy of ezetimibe monotherapy in 1624 primary hypercholesterolaemic patients for up to 2 years.

International journal of clinical practice·2008
Same author

Postischemic regulation of central histamine receptors.

Neuroscience·2005
Same author

Traumatic brain injury results in mast cell increase and changes in regulation of central histamine receptors.

Neuropathology and applied neurobiology·2005
Same author

Evaluation of the efficacy, safety, and tolerability of ezetimibe in primary hypercholesterolaemia: a pooled analysis from two controlled phase III clinical studies.

International journal of clinical practice·2003
Same author

Growth associated protein-43 (GAP-43) and L-histidine decarboxylase (HDC) expression levels in tuberomammillary (TM) nucleus of rats with unilateral striatal lesions.

Inflammation research : official journal of the European Histamine Research Society ... [et al.]·2002
Same author

Ethical, medical and legal issues for the use of placebos in future lipid intervention trials.

Current opinion in lipidology·2002

Area of Science:

  • Pharmacology
  • Clinical Therapeutics
  • Drug Metabolism

Background:

  • Fibrates are widely prescribed for dyslipidemia, effectively lowering cholesterol and triglycerides while raising HDL cholesterol.
  • These lipid-lowering drugs have demonstrated significant benefits in reducing coronary heart disease morbidity and mortality.
  • Despite their efficacy, fibrates possess pharmacological properties that predispose them to clinically relevant drug interactions.

Purpose of the Study:

  • To review the pharmacological properties of fibrates that contribute to drug interactions.
  • To highlight the clinical significance of these potential interactions for patient safety and therapeutic outcomes.
  • To emphasize the importance of awareness regarding fibrate drug interactions for optimal clinical application.

Main Methods:

  • Review of pharmacological properties of fibrates related to drug interactions.
  • Analysis of known interactions affecting vitamin K kinetics, cytochrome P450, and xenobiotic-metabolizing enzymes.
  • Examination of effects on carbohydrate metabolism and pharmacokinetic interactions with antidiabetic drugs.

Main Results:

  • Fibrates exhibit high plasma protein binding, alter vitamin K kinetics, induce endoplasmic reticulum hyperplasia, and affect cytochrome P450 and other metabolizing enzymes.
  • Interactions can directly impact carbohydrate metabolism and lead to pharmacokinetic interactions with antidiabetic drugs.
  • While not always risky, these interactions can influence the long-term safety and therapeutic efficacy of fibrates.

Conclusions:

  • Fibrates are valuable therapeutic agents for dyslipidemia and cardiovascular risk reduction.
  • Awareness and understanding of potential drug interactions associated with fibrates are essential for safe and effective clinical practice.
  • Continued monitoring and consideration of drug interactions will optimize the use of fibrates in patient care.

Related Experiment Videos